Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology
Beata Leskova, Ilaria D’Agostino, Simona Mattova, Nicol Urbanska, Alzbeta Blicharova, Patrik Simko, Aylin Toplu, Muhammet Karaman, Terezia Kiskova-Simkova · 2026
Read Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology by Beata Leskova, Ilaria D’Agostino, Simona Mattova, Nicol Urbanska, Alzbeta Blicharova, Patrik Simko, Aylin Toplu, Muhammet Karaman, Terezia Kiskova-Simkova (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13257304.txt.
Description
Beata Leskova and co-authors survey brain cancer biology and drug research in a 2026 review. Tumors of the central nervous system cause heavy illness and death despite being uncommon. Modern classification now joins tissue appearance with molecular features, changing how cases are named and graded.
Key diagnostic markers, gene changes, and epigenetic shifts are organized for readers across the major tumor types. Multi-omics profiling and artificial intelligence tools are presented as ways to capture tumor diversity. Treatment sections cover targeted drugs, combinations, and new molecular targets, with resistance as a central obstacle. Glioblastoma receives special weight as the most common malignant adult type with stubbornly poor survival. Neuro-oncology readers gain one map from diagnosis to experimental therapy, aimed at personal care.
Catalog record
| CREATOR | Beata Leskova, Ilaria D’Agostino, Simona Mattova, Nicol Urbanska, Alzbeta Blicharova, Patrik Simko, Aylin Toplu, Muhammet Karaman, Terezia Kiskova-Simkova |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |